Literature DB >> 9224617

Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation.

J Zhang1, S Zhang, P E Murtha, W Zhu, S S Hou, C Y Young.   

Abstract

A monomeric androgen responsive element (ARE) is not sufficient to mediate significant androgen induction of the prostate-specific antigen (PSA) gene. Co-transfection experiments using a series of 5'deletion fragments of the proximal promoter region of the PSA gene linked to bacterial chloramphenicol acetyltransferase (CAT) as a reporter have identified two motif sequences which are indispensable for androgen receptor (AR)-mediated transactivation of the PSA promoter and have been designated as motifs A and B respectively. Of note, motif B alone has very little independent enhancer activity regardless of the presence or absence of androgen, whereas multi-copies of motif A exert androgenic inducibility for a heterologous promoter independent of the presence of ARE. Nucleotide substitutions in either motif significantly decrease the androgen inducibility and the nuclear protein binding ability. Furthermore, gel band shift experiments consistently demonstrate that nuclear proteins can bind these motifs, and they are non-receptor factors. Our data indicate that these two DNA motifs are novel cis -regulatory elements and exhibit different mechanisms in cooperation with ARE for AR-mediated transactivation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224617      PMCID: PMC146840          DOI: 10.1093/nar/25.15.3143

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  39 in total

Review 1.  Expression and androgenic regulation of human prostate-specific kallikreins.

Authors:  C Y Young; P E Andrews; D J Tindall
Journal:  J Androl       Date:  1995 Mar-Apr

2.  Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription.

Authors:  S Halachmi; E Marden; G Martin; H MacKay; C Abbondanza; M Brown
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

Review 3.  Role of androgens in prostatic cancer.

Authors:  J T Isaacs
Journal:  Vitam Horm       Date:  1994       Impact factor: 3.421

Review 4.  Molecular mechanisms of androgen action.

Authors:  J Lindzey; M V Kumar; M Grossman; C Young; D J Tindall
Journal:  Vitam Horm       Date:  1994       Impact factor: 3.421

5.  Interaction of thyroid-hormone receptor with a conserved transcriptional mediator.

Authors:  J W Lee; F Ryan; J C Swaffield; S A Johnston; D D Moore
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

Review 6.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members.

Authors:  M J Tsai; B W O'Malley
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

7.  Androgen and glucocorticoid receptors interact with insulin degrading enzyme.

Authors:  S R Kupfer; E M Wilson; F S French
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

8.  cDNA cloning of a new putative ATPase subunit p45 of the human 26S proteasome, a homolog of yeast transcriptional factor Sug1p.

Authors:  K Akiyama; K Yokota; S Kagawa; N Shimbara; G N DeMartino; C A Slaughter; C Noda; K Tanaka
Journal:  FEBS Lett       Date:  1995-04-17       Impact factor: 4.124

9.  In vivo footprinting of an androgen-dependent enhancer reveals an accessory element integral to hormonal response.

Authors:  C O Scarlett; D M Robins
Journal:  Mol Endocrinol       Date:  1995-04

10.  The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18.

Authors:  B Le Douarin; C Zechel; J M Garnier; Y Lutz; L Tora; P Pierrat; D Heery; H Gronemeyer; P Chambon; R Losson
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  11 in total

1.  Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).

Authors:  Eleftherios P Diamandis; Frank Z Stanczyk; Sarah Wheeler; Anu Mathew; Martin Stengelin; Galina Nikolenko; Eli N Glezer; Marshall D Brown; Yingye Zheng; Yen-Hao Chen; Hsiao-Li Wu; Ricardo Azziz
Journal:  Clin Chem Lab Med       Date:  2017-10-26       Impact factor: 3.694

2.  The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells.

Authors:  Shen Gao; Peng Lee; Hua Wang; William Gerald; Michael Adler; Liying Zhang; Yun-Fang Wang; Zhengxin Wang
Journal:  Mol Endocrinol       Date:  2005-02-24

3.  Intronic DNA elements regulate androgen-dependent expression of the murine Nkx3.1 gene.

Authors:  Chinatsu Kojima; Yan Zhang; Warren E Zimmer
Journal:  Gene Expr       Date:  2010

4.  Purification and identification of a novel complex which is involved in androgen receptor-dependent transcription.

Authors:  Keiko Hosohata; Peng Li; Yoshiaki Hosohata; Jun Qin; Robert G Roeder; Zhengxin Wang
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 5.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

6.  Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide.

Authors:  Nicholas G Nickols; Peter B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-12       Impact factor: 11.205

7.  Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.

Authors:  Bekir Cinar; Fan Yeung; Hiroyuki Konaka; Marty W Mayo; Michael R Freeman; Haiyen E Zhau; Leland W K Chung
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

8.  Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women.

Authors:  Emma Eklund; Eleftherios P Diamandis; Carla Muytjens; Sarah Wheeler; Anu Mathew; Martin Stengelin; Eli Glezer; Galina Nikolenko; Marshall D Brown; Yingye Zheng; Angelica Lindén Hirschberg
Journal:  F1000Res       Date:  2017-07-17

9.  Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.

Authors:  Indranil Chattopadhyay; Jianmin Wang; Maochun Qin; Lingqiu Gao; Renae Holtz; Robert L Vessella; Robert W Leach; Irwin H Gelman
Journal:  Oncotarget       Date:  2017-02-07

10.  Allelic variability in PSA & AR genes: a novel biomarker on the horizon for carcinoma prostate.

Authors:  P N Dogra
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.